4.7 Review

Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines

期刊

PEDIATRICS
卷 126, 期 4, 页码 746-759

出版社

AMER ACAD PEDIATRICS
DOI: 10.1542/peds.2009-3207

关键词

Noonan syndrome; PTPN11; SOS1; BRAF; KRAS; NRAS; RAF1; SHOC2; Ras/MAPK signal transduction; congenital heart disease; short stature

资金

  1. Novo Nordisk

向作者/读者索取更多资源

Noonan syndrome (NS) is a common, clinically and genetically heterogeneous condition characterized by distinctive facial features, short stature, chest deformity, congenital heart disease, and other comorbidities. Gene mutations identified in individuals with the NS phenotype are involved in the Ras/MAPK (mitogen-activated protein kinase) signal transduction pathway and currently explain similar to 61% of NS cases. Thus, NS frequently remains a clinical diagnosis. Because of the variability in presentation and the need for multidisciplinary care, it is essential that the condition be identified and managed comprehensively. The Noonan Syndrome Support Group (NSSG) is a nonprofit organization committed to providing support, current information, and understanding to those affected by NS. The NSSG convened a conference of health care providers, all involved in various aspects of NS, to develop these guidelines for use by pediatricians in the diagnosis and management of individuals with NS and to provide updated genetic findings. Pediatrics 2010;126:746-759

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据